Oligonucleotide based artificial nuclease (OBAN) systems.: Bulge size dependence and positioning of catalytic group in cleavage of RNA-bulges

被引:47
作者
Åström, H
Williams, NH
Strömberg, R
机构
[1] Karolinska Inst, Scheele Lab, MBB, Div Organ & Bioorgan Chem, S-17177 Stockholm, Sweden
[2] Univ Sheffield, Dept Chem, Krebs Inst Biomol Sci, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England
关键词
D O I
10.1039/b212216b
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Three zinc ion dependent oligonucleotide based artificial nucleases (OBANs) have been synthesized. These consist of 2'-O-methyloligoribonucleosides connected to 5-amino-2,9-dimethylphenanthroline via a urea function to a linker extending either from C-5 of deoxyuridine or from the T-position of uridine moieties. Both types of linkers are placed centrally in the modified sequence and in addition one OBAN carries the C-5 modified dU as an additional nucleoside unit at the 5'-end. All three OBANs are shown to cleave target oligoribonucleotides selectively. The target RNA's are varied to form differently sized bulges (0-5 nucleotides (nt)) and the different OBANs have different preferences for which sizes are preferentially cleaved. The OBAN with the,centrally positioned C-5 linked zinc chelate preferentially cleaves 3 and 4-nt bulges, the OBAN with the T-linked chelate has a preference for slightly smaller bulges and the OBAN with a 5'-end chelate is more efficient the larger the bulge is. In addition the OBAN with the centrally positioned C-5 linked zinc chelate is. shown to be a real enzyme, capable of turnover of substrate and displaying Michaelis-Menten behaviour. The main differences in efficiency of cleavage between the different OBAN-RNA substrate combinations are likely to be due to proximity factors i.e. the positioning of a catalytic group relative to cleaved phosphodiester functions. The model systems investigated partially display the importance of catalytic group positioning and should be useful in future development of more efficient OBANs.
引用
收藏
页码:1461 / 1465
页数:5
相关论文
共 36 条
[1]   Antisense therapeutics: is it as simple as complementary base recognition? [J].
Agrawal, S ;
Kandimalla, ER .
MOLECULAR MEDICINE TODAY, 2000, 6 (02) :72-81
[2]   Antisense therapeutics [J].
Agrawal, S ;
Zhao, QY .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :519-528
[3]   A method for synthesis of an artificial ribonuclease [J].
Åström, H ;
Strömberg, R .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :1385-1388
[4]   SEQUENCE-SPECIFIC CLEAVAGE OF HIV MESSENGER-RNA BY A RIBOZYME MIMIC [J].
BASHKIN, JK ;
FROLOVA, EI ;
SAMPATH, US .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (13) :5981-5982
[5]   Building blocks for ribozyme mimics: Conjugates of terpyridine and bipyridine with nucleosides [J].
Bashkin, JK ;
Xie, J ;
Daniher, AT ;
Sampath, U ;
Kao, JLF .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (07) :2314-2321
[6]   Chemical nucleases [J].
Cowan, JA .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (06) :634-642
[7]  
Crooke ST, 1996, MED RES REV, V16, P319, DOI 10.1002/(SICI)1098-1128(199607)16:4<319::AID-MED2>3.0.CO
[8]  
2-#
[9]   Antisense therapeutics [J].
Crooke, ST .
BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL. 15, 1998, 15 :121-157
[10]   Antisense therapeutics: lessons from early clinical trials [J].
Flaherty, KT ;
Stevenson, JP ;
O'Dwyer, PJ .
CURRENT OPINION IN ONCOLOGY, 2001, 13 (06) :499-505